No black box warning on record for Colistimethate

As of the latest FDA labeling reviewed, Colistimethate (COLISTIMETHATE SODIUM) does not carry a black box warning. Standard warnings and precautions still apply — see the full Colistimethate medicine page for the complete safety profile.

Other warnings & precautions

WARNINGS Maximum daily dose calculated from colistin base activity should not exceed 5 mg/kg/day with normal renal function. Transient neurological disturbances may occur. These include circumoral paresthesia or numbness, tingling or formication of the extremities, generalized pruritus, vertigo, dizziness, and slurring of speech. For these reasons, patients should be warned not to drive vehicles o

No black box warning on record for Colistimethate

Other warnings & precautions

WARNINGS Maximum daily dose calculated from colistin base activity should not exceed 5 mg/kg/day with normal renal function. Transient neurological disturbances may occur. These include circumoral paresthesia or numbness, tingling or formication of the extremities, generalized pruritus, vertigo, dizziness, and slurring of speech. For these reasons, patients should be warned not to drive vehicles o

Colistimethate Black Box Warning

No black box warning on record for Colistimethate

Other warnings & precautions

Colistimethate Black Box Warning

No black box warning on record for Colistimethate

Other warnings & precautions